[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA2820541A1 - Caspase inhibitors and uses thereof - Google Patents

Caspase inhibitors and uses thereof Download PDF

Info

Publication number
CA2820541A1
CA2820541A1 CA2820541A CA2820541A CA2820541A1 CA 2820541 A1 CA2820541 A1 CA 2820541A1 CA 2820541 A CA2820541 A CA 2820541A CA 2820541 A CA2820541 A CA 2820541A CA 2820541 A1 CA2820541 A1 CA 2820541A1
Authority
CA
Canada
Prior art keywords
disease
compound
formula
compound according
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2820541A
Other languages
English (en)
French (fr)
Inventor
Jean-Damien Charrier
Steven Durrant
Michael Mortimore
Michael O'donnell
Alistair Rutherford
Sharn Ramaya
John R. Studley
Martin Trudeau
Adam Looker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Priority claimed from CA2557645A external-priority patent/CA2557645C/en
Publication of CA2820541A1 publication Critical patent/CA2820541A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2820541A 2004-02-27 2005-02-28 Caspase inhibitors and uses thereof Abandoned CA2820541A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US54861004P 2004-02-27 2004-02-27
US60/548,610 2004-02-27
US62966104P 2004-11-19 2004-11-19
US62974304P 2004-11-19 2004-11-19
US60/629,661 2004-11-19
US60/629,743 2004-11-19
CA2557645A CA2557645C (en) 2004-02-27 2005-02-28 Caspase inhibitors and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2557645A Division CA2557645C (en) 2004-02-27 2005-02-28 Caspase inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
CA2820541A1 true CA2820541A1 (en) 2005-09-15

Family

ID=37959787

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2820541A Abandoned CA2820541A1 (en) 2004-02-27 2005-02-28 Caspase inhibitors and uses thereof

Country Status (2)

Country Link
CN (1) CN1942466B (zh)
CA (1) CA2820541A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979403A (zh) * 2010-09-13 2011-02-23 沈陵陵 新型半胱氨酸天冬氨酸广谱蛋白酶抑制剂及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
EP2261233A3 (en) * 1998-03-19 2011-04-20 Vertex Pharmaceuticals Incorporated Inhibitors of caspases
PE20011350A1 (es) * 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)

Also Published As

Publication number Publication date
CN1942466A (zh) 2007-04-04
CN1942466B (zh) 2011-02-23

Similar Documents

Publication Publication Date Title
US20100105914A1 (en) Caspase inhibitors and uses thereof
CA3183740A1 (en) Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
DE60014345T2 (de) Makrozyklische peptide als hepatitis c virus ns3 protease inhibitore
CA2324226C (en) Inhibitors of caspases
AU735075B2 (en) Inhibitors of interleukin-1beta converting enzyme
CN112218859A (zh) 蛋白水解调节剂及相关使用方法
JP2023530627A (ja) システインプロテアーゼの阻害剤及びその使用方法
RU2427582C2 (ru) Пролекарства ингибитора каспазы
JP2020528918A (ja) アンドロゲン受容体の標的化分解のための化合物および方法
CN113164775A (zh) 用于迅速加速性纤维肉瘤多肽的靶向降解的多环化合物和方法
KR20180029061A (ko) 단백질 분해의 알라닌계 조절인자 및 관련된 이용 방법
CA3199074A1 (en) Compounds and methods for the targeted degradation of androgen receptor protein
JP2009046511A (ja) イミダゾールおよびベンゾイミダゾールカスパーゼのインヒビターならびにそれらの使用
RU2412936C2 (ru) Производные 3-[2-(3-ациламино-2-оксо-2н-пиридин-1-ил)-ацетиламино]-4-оксо-пентановой кислоты и их применение в качестве ингибиторов каспазы
JPH058191B2 (zh)
AU2009263076A1 (en) New heterocyclic carboxamides for use as thrombin inhibitors
CN101006097B (zh) Vla-4拮抗剂
CA2820541A1 (en) Caspase inhibitors and uses thereof
AU2011226946B2 (en) Caspase Inhibitors and Uses Thereof
MXPA06009771A (en) Caspase inhibitors and uses thereof
CA2252918A1 (en) Hiv protease inhibitors useful for the treatment of aids
KR20190032534A (ko) C5a 수용체 길항제로서의 시클릭 펩티드
AU2006233208A1 (en) Hepatitis C virus inhibitors
AU2007200251A1 (en) Inhibitors of Caspases
JPS6054366A (ja) アシル化ヒドラジン化合物、その製造方法及び該化合物を含む医薬製剤

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130621

FZDE Dead

Effective date: 20160302